Search research articles
Contact Us
Filters
Showing results (171-180 of 177) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 177 results.
Controlled Clinical Trials
|
December 12, 2001
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience
J T Wright, W C Cushman, B R Davis, et al.
Controlled Clinical Trials
|
February 13, 2001
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
S L Pressel, B R Davis, J T Wright, et al.
The New England Journal of Medicine
|
March 24, 1983
Hemorrhagic colitis associated with a rare Escherichia coli serotype
L W Riley, R S Remis, S D Helgerson, et al.
JAMA
|
December 18, 1996
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group
J D Curb, S L Pressel, J A Cutler, et al.
Archives of Internal Medicine
|
April 29, 1998
Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group
P J Savage, S L Pressel, J D Curb, et al.
American Journal of Hypertension
|
April 1, 1996
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group
B R Davis, J A Cutler, D J Gordon, et al.
JAMA
|
July 16, 1997
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group
J B Kostis, B R Davis, J Cutler, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 177) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 177 results.
Controlled Clinical Trials
|
December 12, 2001
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience
J T Wright, W C Cushman, B R Davis, et al.
Controlled Clinical Trials
|
February 13, 2001
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
S L Pressel, B R Davis, J T Wright, et al.
The New England Journal of Medicine
|
March 24, 1983
Hemorrhagic colitis associated with a rare Escherichia coli serotype
L W Riley, R S Remis, S D Helgerson, et al.
JAMA
|
December 18, 1996
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group
J D Curb, S L Pressel, J A Cutler, et al.
Archives of Internal Medicine
|
April 29, 1998
Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group
P J Savage, S L Pressel, J D Curb, et al.
American Journal of Hypertension
|
April 1, 1996
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group
B R Davis, J A Cutler, D J Gordon, et al.
JAMA
|
July 16, 1997
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group
J B Kostis, B R Davis, J Cutler, et al.
Page
of 18